Lynch syndrome related endometrial cancer: Clinical significance beyond the endometrium

Journal of Hematology and Oncology

Volumn 6, Issue 1, 2013, Pages

  Wang, Yiying ^a,b   Wang, Yue ^a,b   Li, Jie ^b,c   Cragun, Janiel ^b,d   Hatch, Kenneth ^b,d   Chambers, Setsuko K ^b,d   Zheng, Wenxin ^b,c,d  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c SHANDONG UNIVERSITY   (China)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; ENDOMETRIUM CANCER; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; REVIEW;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; ENDOMETRIAL NEOPLASMS; FEMALE; GENETIC TESTING; HUMANS; PROGNOSIS;

EID: 84875316212     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-6-22     Document Type: Review

References (36)

1. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Aaltonen L, Johns L, Jarvinen H, Mecklin JP, Houlston R, Clin Cancer Res 2007 13 356 361 10.1158/1078-0432.CCR- 06-1256 17200375
2. Hereditary colorectal cancer. Lynch HT, de la Chapelle A, N Engl J Med 2003 348 919 932 10.1056/NEJMra012242 12621137
3. Microsatellite instability and colorectal cancer. Geiersbach KB, Samowitz WS, Arch Pathol Lab Med 2011 135 1269 1277 10.5858/arpa.2011-0035-RA 21970482
4. Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S, Bandipalliam P, Chen LM, Allen B, Conrad P, Terdiman J, Sun C, Daniels M, Burke T, Gershenson DM, Lynch H, Lynch P, Broaddus RR, Obstet Gynecol 2005 105 569 574 10.1097/01.AOG.0000154885.44002.ae 15738026
5. Endometrial cancer as a familial tumor: pathology and molecular carcinogenesis (review). Banno K, Yanokura M, Kobayashi Y, Kawaguchi M, Nomura H, Hirasawa A, Susumu N, Aoki D, Curr Genomics 2009 10 127 132 10.2174/138920209787847069 19794885
6. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, Guimbaud R, Buecher B, Bignon YJ, Caron O, Colas C, Nogues C, Lejeune-Dumoulin S, Olivier-Faivre L, Polycarpe-Osaer F, Nguyen TD, Desseigne F, Saurin JC, Berthet P, Leroux D, Duffour J, Manouvrier S, Frebourg T, Sobol H, Lasset C, Bonaiti-Pellie C, JAMA 2011 305 2304 2310 10.1001/jama.2011.743 21642682
7. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, La Jeunesse J, Nakagawa H, Westman JA, Prior TW, Clendenning M, Penzone P, Lombardi J, Dunn P, Cohn DE, Copeland L, Eaton L, Fowler J, Lewandowski G, Vaccarello L, Bell J, Reid G, de la Chapelle A, Cancer Res 2006 66 7810 7817 10.1158/0008-5472.CAN-06-1114 16885385
8. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, Young J, Winship I, Dowty JG, White DM, Hopper JL, Baglietto L, Jenkins MA, de la Chapelle A, Gastroenterology 2008 135 419 428 10.1053/j.gastro.2008.04.026 18602922
9. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Jass JR, Cottier DS, Jeevaratnam P, Pokos V, Holdaway KM, Bowden ML, Van de Water NS, Browett PJ, Lancet 1995 346 1200 1201 10.1016/S0140-6736(95)92902-9 7475662
10. Role of DNA mismatch repair defects in the pathogenesis of human cancer. Peltomaki P, J Clin Oncol 2003 21 1174 1179 10.1200/JCO.2003.04.060 12637487
11. Mutations associated with HNPCC predisposition-Update of ICG-HNPCC/INSiGHT mutation database. Peltomaki P, Vasen H, Dis Markers 2004 20 269 276 15528792
12. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, Sandkuijl L, Moller P, Genuardi M, Van Houwelingen H, Tops C, Van Puijenbroek M, Verkuijlen P, Kenter G, Van Mil A, Meijers-Heijboer H, Tan GB, Breuning MH, Fodde R, Wijnen JT, Brocker-Vriends AH, Vasen H, Gastroenterology 2004 127 17 25 10.1053/j.gastro.2004.03.068 15236168
13. Cancer risk associated with germline DNA mismatch repair gene mutations. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B, Hum Mol Genet 1997 6 105 110 10.1093/hmg/6.1.105 9002677
14. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ, Int J Cancer 1995 64 430 433 10.1002/ijc. 2910640613 8550246
15. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. Lu KH, Schorge JO, Rodabaugh KJ, Daniels MS, Sun CC, Soliman PT, White KG, Luthra R, Gershenson DM, Broaddus RR, J Clin Oncol 2007 25 5158 5164 10.1200/JCO.2007.10.8597 17925543
16. Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. Resnick KE, Hampel H, Fishel R, Cohn DE, Gynecol Oncol 2009 114 128 134 10.1016/j.ygyno.2009.03.003 19375789
17. Comment on: Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer Patients. Hampel H, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, LaJeunesse J, Nakagawa H, Westman JA, Prior TW, Clendenning M, de la Chapelle A, Frankel W, Penzone P, Cohn DE, Copeland L, Eaton L, Fowler J, Lombardi J, Dunn P, Bell J, Reid G, Lewandowski G, Vaccarello L, Cancer Res 2007 67 9603 10.1158/0008-5472.CAN-07-2308 17909073
18. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries. Ryan P, Mulligan AM, Aronson M, Ferguson SE, Bapat B, Semotiuk K, Holter S, Kwon J, Kalloger SE, Gilks CB, Gallinger S, Pollett A, Clarke BA, Cancer 2012 118 681 688 10.1002/cncr.26323 21721000
19. Gynecologic Cancers in Lynch Syndrome/HNPCC. Lu KH, Broaddus RR, Fam Cancer 2005 4 249 254 10.1007/s10689-005-1838-3 16136386
20. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome? Soliman PT, Broaddus RR, Schmeler KM, Daniels MS, Gonzalez D, Slomovitz BM, Gershenson DM, Lu KH, J Clin Oncol 2005 23 9344 9350 10.1200/JCO.2005.03.5915 16361634
21. The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome. Watson P, Vasen HF, Mecklin JP, Bernstein I, Aarnio M, Jarvinen HJ, Myrhoj T, Sunde L, Wijnen JT, Lynch HT, Int J Cancer 2008 123 444 449 10.1002/ijc.23508 18398828
22. Role of heredity in multiple primary cancer. Lynch HT, Harris RE, Lynch PM, Guirgis HA, Lynch JF, Bardawil WA, Cancer 1977 40 1849 1854 10.1002/1097-0142(197710)40:4+<1849::AID-CNCR2820400813>3.0.CO;2-U 907988
23. Clinical features of colorectal carcinoma in cancer family syndrome. Mecklin JP, Jarvinen HJ, Dis Colon Rectum 1986 29 160 164 10.1007/BF02555012 3943429
24. Lynch syndrome-related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types. Carcangiu ML, Radice P, Casalini P, Bertario L, Merola M, Sala P, Int J Surg Pathol 2010 18 21 26 10.1177/1066896909332117 19443869
25. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. Broaddus RR, Lynch HT, Chen LM, Daniels MS, Conrad P, Munsell MF, White KG, Luthra R, Lu KH, Cancer 2006 106 87 94 10.1002/cncr.21560 16323174
26. Uterine carcinosarcoma associated with hereditary nonpolyposis colorectal cancer. South SA, Hutton M, Farrell C, Mhawech-Fauceglia P, Rodabaugh KJ, Obstet Gynecol 2007 110 543 545 10.1097/01.AOG.0000275262.60526.01 17666659
27. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset. Garg K, Shih K, Barakat R, Zhou Q, Iasonos A, Soslow RA, Am J Surg Pathol 2009 33 1869 1877 10.1097/PAS.0b013e3181bc9866 19898223
28. Carcinoma of the endometrium. II. Papillary adenocarcinoma: a clinical pathological study, 46 cases. Christopherson WM, Alberhasky RC, Connelly PJ, Am J Clin Pathol 1982 77 534 540 7081149
29. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. Balmana J, Stockwell DH, Steyerberg EW, Stoffel EM, Deffenbaugh AM, Reid JE, Ward B, Scholl T, Hendrickson B, Tazelaar J, Burbidge LA, Syngal S, JAMA 2006 296 1469 1478 10.1001/jama.296.12.1469 17003395
30. Prediction of germline mutations and cancer risk in the Lynch syndrome. Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K, Watson P, Gruber SB, Euhus D, Kinzler KW, Jass J, Gallinger S, Lindor NM, Casey G, Ellis N, Giardiello FM, Offit K, Parmigiani G, JAMA 2006 296 1479 1487 10.1001/jama.296.12.1479 17003396
31. Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome. Westin SN, Lacour RA, Urbauer DL, Luthra R, Bodurka DC, Lu KH, Broaddus RR, J Clin Oncol 2008 26 5965 5971 10.1200/JCO.2008.18.6296 19001318
32. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Goodfellow PJ, Buttin BM, Herzog TJ, Rader JS, Gibb RK, Swisher E, Look K, Walls KC, Fan MY, Mutch DG, Proc Natl Acad Sci U S A 2003 100 5908 5913 10.1073/pnas.1030231100 12732731
33. Microsatellite instability in endometrioid endometrial carcinoma: correlation with clinically relevant pathologic variables. Honore LH, Hanson J, Andrew SE, Int J Gynecol Cancer 2006 16 1386 1392 10.1111/j.1525-1438.2006. 00535.x 16803535
34. Lynch syndrome: form, function, proteins, and basketball. Boland CR, Fishel R, Gastroenterology 2005 129 751 755 16083730
35. Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline. Weissman SM, Burt R, Church J, Erdman S, Hampel H, Holter S, Jasperson K, Kalady MF, Haidle JL, Lynch HT, Palaniappan S, Wise PE, Senter L, J Genet Couns 2012 21 484 493 10.1007/s10897-011-9465-7 22167527
36. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Garg K, Leitao MM Jr, Kauff ND, Hansen J, Kosarin K, Shia J, Soslow RA, Am J Surg Pathol 2009 33 925 933 10.1097/PAS.0b013e318197a046 19238076